These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 2481560

  • 1. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP.
    Brain Res; 1989 Oct 23; 500(1-2):119-30. PubMed ID: 2481560
    [Abstract] [Full Text] [Related]

  • 2. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 23; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 3. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.
    Sivam SP, Cox J.
    Brain Res; 2006 Feb 16; 1073-1074():159-63. PubMed ID: 16455064
    [Abstract] [Full Text] [Related]

  • 4. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK, McGinty JF, Hong JS.
    Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976
    [Abstract] [Full Text] [Related]

  • 5. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
    Sivam SP, Breese GR, Krause JE, Napier TC, Mueller RA, Hong JS.
    J Neurochem; 1987 Nov 15; 49(5):1623-33. PubMed ID: 2889804
    [Abstract] [Full Text] [Related]

  • 6. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD, De Ceballos ML, Rose S, Jenner P, Marsden CD.
    Eur J Pharmacol; 1992 Aug 25; 219(2):183-92. PubMed ID: 1385171
    [Abstract] [Full Text] [Related]

  • 7. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul 25; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 8. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK, Wang JY.
    Chin J Physiol; 1991 Jul 25; 34(4):413-25. PubMed ID: 1687937
    [Abstract] [Full Text] [Related]

  • 9. The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion.
    Sivam SP, Krause JE.
    Brain Res; 1990 Dec 17; 536(1-2):169-75. PubMed ID: 1707718
    [Abstract] [Full Text] [Related]

  • 10. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
    Sivam SP.
    J Pharmacol Exp Ther; 1989 Sep 17; 250(3):818-24. PubMed ID: 2476548
    [Abstract] [Full Text] [Related]

  • 11. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
    Okamura H, Murakami T, Yokoyama C, Nakamura T, Ibata Y.
    J Pharmacol Exp Ther; 1997 Feb 17; 280(2):1031-7. PubMed ID: 9023320
    [Abstract] [Full Text] [Related]

  • 12. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C, Okamura H.
    J Pharmacol Exp Ther; 1997 Feb 17; 280(2):1016-30. PubMed ID: 9023319
    [Abstract] [Full Text] [Related]

  • 13. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 17; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 14. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution.
    Caboche J, Rogard M, Besson MJ.
    Brain Res Dev Brain Res; 1991 Jan 15; 58(1):111-22. PubMed ID: 1849802
    [Abstract] [Full Text] [Related]

  • 15. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Jan 15; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 16. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR.
    Science; 1990 Dec 07; 250(4986):1429-32. PubMed ID: 2147780
    [Abstract] [Full Text] [Related]

  • 17. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS, Fine A, Robertson HA.
    Brain Res; 1991 Jan 25; 539(2):304-11. PubMed ID: 1675908
    [Abstract] [Full Text] [Related]

  • 18. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M, Mennicken F, Chritin M, Abrous DN, Feuerstein C, Le Moal M, Herman JP.
    Neuroscience; 1992 Jan 25; 46(3):729-38. PubMed ID: 1532053
    [Abstract] [Full Text] [Related]

  • 19. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1995 Oct 25; 275(1):237-44. PubMed ID: 7562556
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec 25; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.